Clinical Trials Detalhe
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
Visão Geral
Gender
ALL
Idade
N/A
Fase
PHASE2
Tipo de Estudo
INTERVENTIONAL
Localização
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. (Lisbon, Portugal)
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT00025610Sumário
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of different combination chemotherapy regimens in treating infants who have newly diagnosed neuroblastoma.
Condições
Neuroblastoma
Elegibilidade
DISEASE CHARACTERISTICS: * Histologically confirmed newly diagnosed stage IV or IVS neuroblastoma or ganglioneuroblastoma * Metastases confined to marrow, skin, nodes, or liver * No metastases to bone (radiologic bone lesions in skeleton), CNS, pleura, or lung * No MYCN amplification (i.e., fewer than 10 copies) PATIENT CHARACTERISTICS: Age: * Under 12 months at diagnosis Performance status: * Not specified Life expectancy: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * Not specified Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * Not specified